Clinical Trial Update: A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing generic Ingenol Mebutate Gel 0.05% to Picato Gel 0.05% in actinic keratosis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Ingenol Mebutate Gel 0.05% (generic) (ingenol mebutate)
• Picato Gel 0.05% (ingenol mesylate)

Snippet

Sponsor: Actavis Inc. | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2020-05-12